Degromics Bio, Inc.
Degromics Bio, Inc.
  • Home
  • About Us
  • Science
  • Pipeline
  • More
    • Home
    • About Us
    • Science
    • Pipeline
  • Home
  • About Us
  • Science
  • Pipeline

Our Science

Leukemia remains an intractable cancer

MLL-rearranged leukemia represents a highly aggressive subtype

Previous Efforts to target DOT1L have failed

DOT1L possesses non-enzymatic functions that drive proliferation

Degradation of DOT1L will eliminate all of its oncogenic functions

Degromics Bio, Inc.

Copyright © 2026 Degromics Bio, Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept